How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?

Bibliographic Details
Main Authors:	Alessandro Loglio, Pietro Lampertico
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2020-01-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1476

Similar Items

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
by: Elisabetta Degasperi, et al.
Published: (2022-10-01)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
by: Anna S. Lok, et al.
Published: (2020-01-01)

The Impact of Antiviral Treatment of Hepatitis B Virus after Kidney Transplant and the Latest Insights
by: Fabrizio Fabrizi, et al.
Published: (2023-02-01)

Current Trend in Antiviral Therapy for Chronic Hepatitis B
by: Rong-Nan Chien, et al.
Published: (2022-02-01)

Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment
by: Lisa Sandmann, et al.
Published: (2024-02-01)

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients
by: Viva Finhar Insani Nirmala, et al.
Published: (2023-04-01)

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
by: Takehisa Watanabe, et al.
Published: (2021-10-01)

Quantitative hepatitis B e antigen: a better predictor of hepatitis B virus DNA than quantitative hepatitis B surface antigen
by: Hudu, Shuaibu A., et al.
Published: (2018)

The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis
by: Danqing Hu, et al.
Published: (2024-04-01)

Hepatitis B functional cure and immune response
by: Jia-Rui Zheng, et al.
Published: (2022-11-01)

Viral hepatitis B and C. Cure or treatment?
by: Dimitrios A. Kountouras
Published: (2014-12-01)

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
by: Mark A. Feitelson, et al.
Published: (2022-09-01)

Advances in new antivirals for chronic hepatitis B
by: Yanhua Tang, et al.
Published: (2022-03-01)

Progress of hepatitis B virus-associated neutralizing antibody in antiviral therapy of chronic hepatitis B
by: Zhao Yudi, Huang Mingxing
Published: (2022-11-01)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
by: Zeynep Gök Sargın
Published: (2023-03-01)

Cytokines and Chemokines Involved in Hepatitis B Surface Antigen Loss in Human Immunodeficiency Virus/Hepatitis B Virus Coinfected Patients
by: Noboru Urata, et al.
Published: (2021-02-01)

Detection of hepatitis B surface antigen
by: Tan, Wen Siang, et al.
Published: (2004)

Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment
by: Tanner Grudda, et al.
Published: (2022-09-01)

Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
by: Baiguo Xu, et al.
Published: (2022-10-01)

Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study
by: Gian Paolo Caviglia, et al.
Published: (2021-07-01)

Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-Analysis
by: Eleonora Morais, et al.
Published: (2023-01-01)

Linvencovir: Paving the way for functional cure in hepatitis B
by: Jiwon Yang, et al.
Published: (2024-04-01)

Hepatitis B Virus Cure: Targets and Future Therapies
by: Hye Won Lee, et al.
Published: (2020-12-01)

Development of antiviral strategies for treatment of chronic hepatitis B
by: Seow, Heng Fong, et al.
Published: (2002)

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
by: Han Ah Lee, et al.
Published: (2022-03-01)

Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure
by: Yisi Liu, et al.
Published: (2023-11-01)

Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA
by: Marc G. Ghany, et al.
Published: (2022-09-01)

Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies
by: Ivana Lazarevic, et al.
Published: (2024-01-01)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
by: Bonolo B. Phinius, et al.
Published: (2023-07-01)

Kloning dan ekspresi gen S penyandi hepatitis b surface antigen (hbsag) virus hepatitis b â�� isolate wiatarawi, lowibok=Cloning and Statement of the S Gene Encoding the Hepatitis B Surface Antigen (HBsAg) of Hepatitis B
by: Perpustakaan UGM, i-lib
Published: (2001)

Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection
by: Lu Zhang, et al.
Published: (2017-01-01)

Prevalence of Antibodies to Hepatitis B Virus Antigens and Occult Hepatitis B Virus Infection in Blood Donors
by: Abdulrazak SH Hasan
Published: (2019-11-01)

Prevalence of Antibodies to Hepatitis B Virus Antigens and Occult Hepatitis B Virus Infection in Blood Donors
by: Abdulrazak SH Hasan
Published: (2019-11-01)

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
by: Ayaka Washizaki, et al.
Published: (2022-09-01)

Chronic Hepatitis B Infection: New Approaches towards Cure
by: Mojisola Ogunnaike, et al.
Published: (2023-08-01)

Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.
by: Tram T Tran, et al.
Published: (2015-01-01)

Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-01-01)

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
by: I-Chin Wu, et al.
Published: (2021-05-01)

Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
by: Lung-Yi Mak, et al.
Published: (2021-06-01)

Potential antiviral activities of chrysin against hepatitis B virus
by: Sajad Ahmad Bhat, et al.
Published: (2023-03-01)